Financials Reflect Scientific, Inc.

Equities

RSCF

US75866F1012

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 14:54:54 2024-05-31 EDT 5-day change 1st Jan Change
0.0579 USD +3.39% Intraday chart for Reflect Scientific, Inc. +1.58% -12.93%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3.06 3.243 42.37 10.16 5.21 5.667
Enterprise Value (EV) 1 2.85 2.756 42.01 8.8 3.885 4.631
P/E ratio -12 x -16.6 x 64.2 x 12 x 58.6 x -6.65 x
Yield - - - - - -
Capitalization / Revenue 1.97 x 2.02 x 15.2 x 3.61 x 2.55 x 5.25 x
EV / Revenue 1.84 x 1.71 x 15 x 3.13 x 1.9 x 4.29 x
EV / EBITDA -11.6 x -14.4 x 64.2 x 10.6 x - -
EV / FCF 41.7 x 6.75 x -200 x 15.3 x -56.6 x 38.4 x
FCF Yield 2.4% 14.8% -0.5% 6.54% -1.77% 2.6%
Price to Book 6.11 x 6.28 x 34.9 x 4.68 x 2.27 x 3.01 x
Nbr of stocks (in thousands) 76,512 79,108 84,739 84,739 84,989 85,214
Reference price 2 0.0400 0.0410 0.5000 0.1199 0.0613 0.0665
Announcement Date 19-04-03 20-03-30 21-03-30 22-03-31 23-03-31 24-03-29
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1.552 1.609 2.793 2.815 2.041 1.08
EBITDA 1 -0.2459 -0.1909 0.6548 0.8316 - -
EBIT 1 -0.2489 -0.1948 0.651 0.8278 0.0901 -0.4673
Operating Margin -16.04% -12.11% 23.31% 29.41% 4.41% -43.26%
Earnings before Tax (EBT) 1 -0.2495 -0.1956 0.6601 0.9391 0.0901 -0.4587
Net income 1 -0.2495 -0.1956 0.6601 0.9391 0.0894 -0.459
Net margin -16.08% -12.15% 23.64% 33.36% 4.38% -42.5%
EPS 2 -0.003343 -0.002472 0.007789 0.0100 0.001046 -0.0100
Free Cash Flow 1 0.0683 0.4083 -0.2099 0.5752 -0.0686 0.1206
FCF margin 4.4% 25.37% -7.52% 20.44% -3.36% 11.17%
FCF Conversion (EBITDA) - - - 69.17% - -
FCF Conversion (Net income) - - - 61.25% - -
Dividend per Share - - - - - -
Announcement Date 19-04-03 20-03-30 21-03-30 22-03-31 23-03-31 24-03-29
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.21 0.49 0.36 1.36 1.32 1.04
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.07 0.41 -0.21 0.58 -0.07 0.12
ROE (net income / shareholders' equity) -51.3% -36.5% 74.8% 55.4% 3.99% -21.9%
ROA (Net income/ Total Assets) -26.5% -14.6% 29.5% 24.9% 2.29% -11.4%
Assets 1 0.9405 1.342 2.235 3.771 3.91 4.02
Book Value Per Share 2 0.0100 0.0100 0.0100 0.0300 0.0300 0.0200
Cash Flow per Share 2 0 0.0100 0.0100 0.0200 0.0200 0.0100
Capex 1 0.01 - - - - -
Capex / Sales 0.69% - - - - -
Announcement Date 19-04-03 20-03-30 21-03-30 22-03-31 23-03-31 24-03-29
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. RSCF Stock
  4. Financials Reflect Scientific, Inc.